The North America monoclonal antibodies market is expected to reach US$ 1,20,713.2 million by 2028 from US$ 54,629.4 million in 2021. The market is estimated to grow at a CAGR of 12.0% from 2021–2028. The scientific community in North America is continually engaged in exploring new monoclonal antibody combinations to enhance efficacy against multiple diseases simultaneously. These...